Submitted by Anonymous (not verified) on 6 January 2026 - 15:12
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 4, Status: Authorised